Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anacetrapib add-on to statins in Chinese patients with hypercholesterolemia
CTR20130982Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of anacetrapib in hypercholesterolemia, Hypo-HDL cholesterolemia (HALP), sponsored by Merck & Co.. Started Oct 2014; status: completed.
02
Drugs
anacetrapib
03
Conditions
hypercholesterolemiaHypo-HDL cholesterolemia (HALP)
Beyond the preview
Go deeper on CTR20130982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130982.